1 reports of this reaction
6.3% of all ALUMINUM SESQUICHLOROHYDRATE reports
#12 most reported adverse reaction
LACRIMATION INCREASED is the #12 most commonly reported adverse reaction for ALUMINUM SESQUICHLOROHYDRATE, manufactured by A.P. Deauville, LLC. There are 1 FDA adverse event reports linking ALUMINUM SESQUICHLOROHYDRATE to LACRIMATION INCREASED. This represents approximately 6.3% of all 16 adverse event reports for this drug.
Patients taking ALUMINUM SESQUICHLOROHYDRATE who experience lacrimation increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
LACRIMATION INCREASED is moderately reported among ALUMINUM SESQUICHLOROHYDRATE users, representing a notable but not dominant share of adverse events.
In addition to lacrimation increased, the following adverse reactions have been reported for ALUMINUM SESQUICHLOROHYDRATE:
The following drugs have also been linked to lacrimation increased in FDA adverse event reports:
LACRIMATION INCREASED has been reported as an adverse event in 1 FDA reports for ALUMINUM SESQUICHLOROHYDRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
LACRIMATION INCREASED accounts for approximately 6.3% of all adverse event reports for ALUMINUM SESQUICHLOROHYDRATE, making it a notable side effect.
If you experience lacrimation increased while taking ALUMINUM SESQUICHLOROHYDRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.